Results 161 to 170 of about 82,921 (179)
Some of the next articles are maybe not open access.

Use of PEG-asparaginase in the treatment of patients with solid tumors

Cancer Chemotherapy and Pharmacology, 2001
J P, Vieira Pinheiro   +2 more
openaire   +2 more sources

#641 PEG-asparaginase reactions are severe and prolonged

Journal of Pediatric Hematology/Oncology, 1996
P. C. Davis   +3 more
openaire   +1 more source

Pharmacokinetics and Immunogenicity of the First Doses of Peg-Asparaginase -an Alltogether Pilot Study

Blood, 2022
Merete Eybye Dam   +15 more
openaire   +1 more source

HLA-DRB1 *16:02 is Associated with PEG-Asparaginase Hypersensitivity

Pharmacogenomics, 2021
Chao Gao, Wei Lin, Shu-Guang Liu
exaly  

Extended enzymatic stability of reconstituted lyophilized PEG-asparaginase in vials

Journal of Oncology Pharmacy Practice, 2021
Ramos-Díaz R, Jesica Diaz Vera
exaly  

L-Asparaginase for the Treatment of Cancer

Ca-A Cancer Journal for Clinicians, 1973
K B Mccredie, E J Freireich
exaly  

Hyperinsulinaemic hypoglyaemia associated with PEG-asparaginase therapy for acute lymphoblastic leukaemia

2023
Hobbs, Annabelle   +3 more
openaire   +2 more sources

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients

Cancer, 2007
Georg Hempel
exaly  

Voriconazole‐induced hepatotoxicity following the administration of PEG‐asparaginase: Case report

Pediatric Blood & Cancer, 2016
Rachel Gallant   +4 more
openaire   +1 more source

Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia

Journal of Pediatric Oncology Nursing, 2018
Belinda Mandrell   +2 more
exaly  
asparaginase
3. good health
polyethylene glycols
humans
diseases of the blood and blood-forming organs
precursor cell lymphoblastic leukemia-lymphoma
antineoplastic agents
acute lymphoblastic leukemia
adolescent
previous   15  16  17  18  

Home - About - Disclaimer - Privacy